propionylcarnitine has been researched along with sildenafil citrate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Silverio, F; Gentile, V; Koverech, A; Prigiotti, G; Vicini, P | 1 |
| Cavallini, G; Koverech, A; Modenini, F; Vitali, G | 1 |
| Buchetti, B; Fallarino, M; Gandini, L; Gatti, A; Jannini, EA; Lenti, L; Lenzi, A; Mandosi, E; Morano, S; Sensi, M; Tiberti, C | 1 |
| Salonia, A | 1 |
| Pickard, R | 1 |
| Canfield, SE; Dhir, RR; Lin, HC; Wang, R | 1 |
1 review(s) available for propionylcarnitine and sildenafil citrate
| Article | Year |
|---|---|
Combination therapy for erectile dysfunction: an update review.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Carnitine; Combined Modality Therapy; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vacuum | 2011 |
3 trial(s) available for propionylcarnitine and sildenafil citrate
| Article | Year |
|---|---|
Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with erectile dysfunction and diabetes.
Topics: Carnitine; Diabetes Complications; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2004 |
Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy.
Topics: Acetylcarnitine; Carnitine; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Prostate; Prostatectomy; Purines; Sildenafil Citrate; Sulfones | 2005 |
Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
Topics: Aged; Antioxidants; Biomarkers; Carnitine; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Erectile Dysfunction; Glycated Hemoglobin; Humans; Male; Middle Aged; Monocytes; Phosphodiesterase Inhibitors; Piperazines; Purines; Reactive Oxygen Species; Sildenafil Citrate; Sulfones | 2007 |
2 other study(ies) available for propionylcarnitine and sildenafil citrate
| Article | Year |
|---|---|
Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
Topics: Antioxidants; Carnitine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Monocytes; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2007 |
Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
Topics: Antioxidants; Carnitine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2007 |